Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
REDUCED EXPRESSION OF PLAKOGLOBIN INDICATES AN UNFAVORABLE PROGNOSIS IN SUBSETS OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
Autore:
PANTEL K; PASSLICK B; VOGT J; STOSIEK P; ANGSTWURM M; SEENHIBLER R; HAUSSINGER K; THETTER O; IZBICKI JR; RIETHMULLER G;
Indirizzi:
UNIV MUNICH,INST IMMUNOL,GOETHESTR 31 D-80336 MUNICH GERMANY UNIV MUNICH,KLINIKUM INNENSTADT,CHIRURG KLIN D-80336 MUNICH GERMANY UNIV HAMBURG,KRANKENHAUS EPPENDORF,KLIN ALLGEMEINCHIRURG D-2000 HAMBURG GERMANY ZENT KRANKENHAUS GAUTING,ABT THORAXCHIRURG & PULM GAUTING GERMANY KLINIKUM COTTBUS,INST PATHOL COTTBUS GERMANY
Titolo Testata:
Journal of clinical oncology
fascicolo: 4, volume: 16, anno: 1998,
pagine: 1407 - 1413
SICI:
0732-183X(1998)16:4<1407:REOPIA>2.0.ZU;2-H
Fonte:
ISI
Lingua:
ENG
Soggetto:
BETA-CATENIN; E-CADHERIN; GENE-PRODUCT; PROTEIN; HETEROZYGOSITY; CONNECTION; MOLECULES; ADHESION; BREAST; COMMON;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
27
Recensione:
Indirizzi per estratti:
Citazione:
K. Pantel et al., "REDUCED EXPRESSION OF PLAKOGLOBIN INDICATES AN UNFAVORABLE PROGNOSIS IN SUBSETS OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER", Journal of clinical oncology, 16(4), 1998, pp. 1407-1413

Abstract

Purpose: Plakoglobin is thought to play a key role in cadherin-mediated epithelial cell adhesion, because it is a common component of desmosomal and nondesmosomal adherens junctions. Because loss of homotypic cell adhesion is an important early step in invasion and metastasis ofsolid tumors, we evaluated the frequency and prognostic significance of a deficient expression of plakoglobin in human lung cancer. Patients and Methods: At primary surgery, representative specimens of the primary tumor were obtained from 96 consecutive patients with completely resected non-small-cell lung carcinoma (NSCLC) without overt distant metastases. Cryostat sections of these specimens and metastatic lymph nodes were stained with monoclonal antibody (mAb) PG 5.1 against plakoglobin, using an immunoperoxidase technique. Patients were monitored for a median of 39 months (range, 12 to 56) after surgery. Results: Absent or severely reduced expression of plakoglobin (ie, < 30% positive tumor cells) was observed in 39 patients (40.6%). There was no significant correlation to established risk factors, such as the histology, extension, and histologic grade of the primary tumor and metastatic lymph node involvement, or expression of alpha-catenin. Expression of plakoglobin in lymph node metastases ranged from 0% to greater than 60% positive tumor cells. Deficient plakoglobin expression on the primary tumor was significantly correlated to a shortened disease-free and overall survival in patients with adenocarcinomas, pT1-2 tumors, or negative lymph nodes (pNO). In patients with pT1-2 tumors, the independence of this prognostic influence from established risk factors was demonstrated by Cox regression analyses (disease-free survival, P = .002; overall survival, P = .038). Conclusion: Deficient expression of plakoglobin appears to be an important event in the progression of NSCLC.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/03/20 alle ore 23:40:55